Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils
Leonie M. Behrens(Cancer Center Amsterdam), Marjolein van Egmond(Amsterdam University Medical Centers)
Cited by 35
Related Papers
Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity
|Journal of Clinical Investigation|2021|59
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness
|Cancer Cell|2024|17
Antagonizing FcαR1 (CD89) as treatment in IgA-mediated chronic inflammation and autoimmunity
|Frontiers in Immunology|2023|12
Fcα Receptor-1-Activated Monocytes Promote B Lymphocyte Migration and IgA Isotype Switching
|International Journal of Molecular Sciences|2022|6